Oct 292014
Nephron Pharmaceuticals Corporation CEO Lou Kennedy (far right) conducts a tour for Capital Rotary Club members during a field trip to the 408,000 square foot West Columbia facility. Though still in start-up stages, Nephron represents a $313 million investment and presently has over 100 employees at the SC location. It will manufacture and distribute respiratory products, eye drops that are preservative and additive free, sterile injectable drugs and oral vaccines. Capital Rotary periodically tours various points of interest throughout the community.